Direkt zum Inhalt
Merck
  • Balancing the rates of new bone formation and polymer degradation enhances healing of weight-bearing allograft/polyurethane composites in rabbit femoral defects.

Balancing the rates of new bone formation and polymer degradation enhances healing of weight-bearing allograft/polyurethane composites in rabbit femoral defects.

Tissue engineering. Part A (2013-08-15)
Jerald E Dumas, Edna M Prieto, Katarzyna J Zienkiewicz, Teja Guda, Joseph C Wenke, Jesse Bible, Ginger E Holt, Scott A Guelcher
ZUSAMMENFASSUNG

There is a compelling clinical need for bone grafts with initial bone-like mechanical properties that actively remodel for repair of weight-bearing bone defects, such as fractures of the tibial plateau and vertebrae. However, there is a paucity of studies investigating remodeling of weight-bearing bone grafts in preclinical models, and consequently there is limited understanding of the mechanisms by which these grafts remodel in vivo. In this study, we investigated the effects of the rates of new bone formation, matrix resorption, and polymer degradation on healing of settable weight-bearing polyurethane/allograft composites in a rabbit femoral condyle defect model. The grafts induced progressive healing in vivo, as evidenced by an increase in new bone formation, as well as a decrease in residual allograft and polymer from 6 to 12 weeks. However, the mismatch between the rates of autocatalytic polymer degradation and zero-order (independent of time) new bone formation resulted in incomplete healing in the interior of the composite. Augmentation of the grafts with recombinant human bone morphogenetic protein-2 not only increased the rate of new bone formation, but also altered the degradation mechanism of the polymer to approximate a zero-order process. The consequent matching of the rates of new bone formation and polymer degradation resulted in more extensive healing at later time points in all regions of the graft. These observations underscore the importance of balancing the rates of new bone formation and degradation to promote healing of settable weight-bearing bone grafts that maintain bone-like strength, while actively remodeling.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Acetonitril, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Trifluoressigsäure, ReagentPlus®, 99%
Sigma-Aldrich
Trifluoressigsäure, suitable for HPLC, ≥99.0%
Sigma-Aldrich
Acetonitril, HPLC Plus, ≥99.9%
Sigma-Aldrich
Kaliumhydroxid, ACS reagent, ≥85%, pellets
Sigma-Aldrich
Trifluoressigsäure, puriss. p.a., suitable for HPLC, ≥99.0% (GC)
Sigma-Aldrich
Acetonitril, ACS reagent, ≥99.5%
Sigma-Aldrich
Kaliumhydroxid, reagent grade, 90%, flakes
Sigma-Aldrich
Acetonitril, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Kalilauge, 45 wt. % in H2O
Sigma-Aldrich
Kaliumhydroxid, semiconductor grade, pellets, 99.99% trace metals basis (Purity excludes sodium content.)
Sigma-Aldrich
Acetonitril, anhydrous, 99.8%
Supelco
Kalilauge, volumetric, 8.0 M KOH (8.0N)
Sigma-Aldrich
Kaliumhydroxid, ≥85% KOH basis, pellets, white
Sigma-Aldrich
Trifluoressigsäure, ≥99%, for protein sequencing
Sigma-Aldrich
Kaliumhydroxid, BioXtra, ≥85% KOH basis
Sigma-Aldrich
Kaliumhydroxid, technical, ≥85%, powder
Sigma-Aldrich
Acetonitril, biotech. grade, ≥99.93%
Sigma-Aldrich
Dabco® 33-LV
Sigma-Aldrich
Kaliumhydroxid, anhydrous, ≥99.95% trace metals basis
USP
Trehalose, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
1,4-Diazabicyclo[2.2.2]octan, ReagentPlus®, ≥99%
Sigma-Aldrich
Acetonitril, ReagentPlus®, 99%
Sigma-Aldrich
Acetonitril, suitable for DNA synthesis, ≥99.9% (GC)
Sigma-Aldrich
Acetonitril, electronic grade, 99.999% trace metals basis
Supelco
Acetonitril, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Trifluoressigsäure, analytical standard
Supelco
Trehalose, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Kaliumhydroxid-Konzentrat, 0.1 M KOH in water (0.1N), Eluent concentrate for IC
USP
Lösungsmittelrückstände Klasse 2 - Acetonitril, United States Pharmacopeia (USP) Reference Standard